, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Keith Wilson
Faculty Member
Last active: 7/6/2020

  1. BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Parang B, Kaz AM, Barrett CW, Short SP, Ning W, Keating CE, Mittal MK, Naik RD, Washington MK, Revetta FL, Smith JJ, Chen X, Wilson KT, Brand T, Bader DM, Tansey WP, Chen R, Brentnall TA, Grady WM, Williams CS (2017) Gut 66(5): 852-862
    › Primary publication · 28389570 (PubMed) · PMC5385850 (PubMed Central)
  2. TLR9 activation suppresses inflammation in response to Helicobacter pylori infection. Varga MG, Piazuelo MB, Romero-Gallo J, Delgado AG, Suarez G, Whitaker ME, Krishna US, Patel RV, Skaar EP, Wilson KT, Algood HM, Peek RM (2016) Am J Physiol Gastrointest Liver Physiol 311(5): G852-G858
    › Primary publication · 27758771 (PubMed) · PMC5130555 (PubMed Central)
  3. The L-Arginine Transporter Solute Carrier Family 7 Member 2 Mediates the Immunopathogenesis of Attaching and Effacing Bacteria. Singh K, Al-Greene NT, Verriere TG, Coburn LA, Asim M, Barry DP, Allaman MM, Hardbower DM, Delgado AG, Piazuelo MB, Vallance BA, Gobert AP, Wilson KT (2016) PLoS Pathog 12(10): e1005984
    › Primary publication · 27783672 (PubMed) · PMC5081186 (PubMed Central)
  4. The Immune Battle against Helicobacter pylori Infection: NO Offense. Gobert AP, Wilson KT (2016) Trends Microbiol 24(5): 366-376
    › Primary publication · 26916789 (PubMed) · PMC4841705 (PubMed Central)
  5. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Gobert AP, Sagrestani G, Delmas E, Wilson KT, Verriere TG, Dapoigny M, Del'homme C, Bernalier-Donadille A (2016) Sci Rep : 39399
    › Primary publication · 27982124 (PubMed) · PMC5159846 (PubMed Central)
  6. The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice. Garay J, Piazuelo MB, Majumdar S, Li L, Trillo-Tinoco J, Del Valle L, Schneider BG, Delgado AG, Wilson KT, Correa P, Zabaleta J (2016) Cancer Lett 371(1): 90-8
    › Primary publication · 26639196 (PubMed) · PMC4714604 (PubMed Central)
  7. Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis. Wiese DM, Horst SN, Brown CT, Allaman MM, Hodges ME, Slaughter JC, Druce JP, Beaulieu DB, Schwartz DA, Wilson KT, Coburn LA (2016) PLoS One 11(5): e0156387
    › Primary publication · 27227540 (PubMed) · PMC4882051 (PubMed Central)
  8. Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system. Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, Romero-Gallo J, Krishna US, Delgado A, Gomez MA, Good JA, Almqvist F, Skaar EP, Correa P, Wilson KT, Hadjifrangiskou M, Peek RM (2016) Oncogene 35(48): 6262-6269
    › Primary publication · 27157617 (PubMed) · PMC5102820 (PubMed Central)
  9. Myeloid translocation genes differentially regulate colorectal cancer programs. Parang B, Bradley AM, Mittal MK, Short SP, Thompson JJ, Barrett CW, Naik RD, Bilotta AJ, Washington MK, Revetta FL, Smith JJ, Chen X, Wilson KT, Hiebert SW, Williams CS (2016) Oncogene 35(49): 6341-6349
    › Primary publication · 27270437 (PubMed) · PMC5140770 (PubMed Central)
  10. L-Arginine Availability and Metabolism Is Altered in Ulcerative Colitis. Coburn LA, Horst SN, Allaman MM, Brown CT, Williams CS, Hodges ME, Druce JP, Beaulieu DB, Schwartz DA, Wilson KT (2016) Inflamm Bowel Dis 22(8): 1847-58
    › Primary publication · 27104830 (PubMed) · PMC4956554 (PubMed Central)